Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): PI0610030-9 (WO2006116764)
Who filed: GTPI
Country: Brazil
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 13-09-2017
Patent type: Molecules

Click within the document, or manually enter the page number below

GTPI opposition, lopinavir/ritonavir (LPV/r) , (PI0413882‐1)

Countries: Brazil Date: 2011
GTPI opposition, lopinavir/ritonavir (LPV/r) , (PP1101190-4 (Divisional of PP1100397-9))

Countries: Brazil Date: 2006
GTPI opposition, tenofovir disoproxil fumarate (TDF) , (PI9811045-4)

Countries: Brazil Date: 2006
GTPI opposition, tenofovir disoproxil fumarate (TDF) , (PI9816239-0 (Divisional to PI9801145-4) )

Countries: Brazil Date: 2009
GTPI opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (PI0406760-6)

Countries: Brazil Date: 2010
GTPI opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (PI0406760-6)

Countries: Brazil Date: 2010
ABIA/GTPI opposition, Atazanavir, (PI0509595-6)

Countries: Brazil Date: 2020
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir Alafenamide Fumarate , (PI0112646-6 - WO200208241)

Countries: Brazil Date: 2016
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Tenofovir disoproxil fumarate/Emtricitabine, (PI0406760-6 - WO2004064845)

Countries: Brazil Date: 2016
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Dolutegravir, (PI0610030-9 (US 2006/016604 - WO 2006/116764))

Countries: Brazil Date: 2019

Gtpi Opposition, Dolutegravir, (Pi0610030 9 (Wo2006116764))